0001203311-17-000036.txt : 20170731
0001203311-17-000036.hdr.sgml : 20170731
20170731191558
ACCESSION NUMBER: 0001203311-17-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170727
FILED AS OF DATE: 20170731
DATE AS OF CHANGE: 20170731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRACHMAN JONATHAN G
CENTRAL INDEX KEY: 0001588467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 17994278
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-07-27
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001588467
DRACHMAN JONATHAN G
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
CMO & EVP, R & D
Common Stock
2017-07-27
4
M
0
10000
10.29
A
125204
D
Common Stock
2017-07-27
4
S
0
10000
54.5361
D
115204
D
Non-Qualified Stock Option (right to buy)
10.29
2017-07-27
4
M
0
10000
0.0
D
2017-08-28
Common Stock
10000
10000
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $54.10 to $54.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Shares vested at a rate of 25% on 8/28/2008 and monthly thereafter until all the shares were fully vested on 8/28/2011.
/s/ Jean Liu
2017-07-28